« Return to News | CROs/Service Providers

Icon reports second quarter 2013 revenue of $334 million

Friday, July 26, 2013 03:03 PM

CRO Icon said net revenues grew 21% to $334.2 million in the second quarter ended June 30, from $277 million in the year-ago quarter. Revenue in the first half of 2013 rose 23% to $651 million, from $529 million a year ago.

Income from operations in the first half of 2013 was $58.3 million, or 9% of revenue, compared with $28.4 million or 5.4% of revenue in the first half of 2012. Income from operations was $30.9 million, or 9.3% of revenue, compared to $16.6 million, or 6% of revenue, in the year-ago quarter. Net income was $26.5 million, up from $12.9 million a year ago. Net income for the first half of 2013 was $48.7 million, compared with $21.9 million in 2012.

Guidance for 2013 has been updated, with revenue expected to be in the range of $1.3 billion to $1.32 billion, and earnings-per-share in the $1.54 to $1.64 range.

Cash generated from operating activities was $10.8 million, after expenditure of $26 million on prior period acquisition earn outs and capital expenditure of $7.8 million. The company’s net cash amounted to $184 million at the end of the second quarter, compared to net cash of $190 million on Dec. 31, 2012. 

During the quarter, the company recorded a charge of $4.6 million for various restructuring costs. U.S. GAAP income from operations after these items amounted to $26 million, or 7.9% of revenue. U.S. GAAP net income for the quarter was $22 million, or 36 cents per share.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.